{
  "docId": "019de517-44b3-71b5-8a8d-243b41bb1797",
  "docSlug": "c77cf9536b998c2f906519be4212f807",
  "documentTitle": "GH Research | Investor Presentation Deck | 30 slides",
  "authorId": "gh-research",
  "authorName": "GH Research",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 20,
  "pageCount": 30,
  "prevPage": 19,
  "nextPage": 21,
  "slideType": "comparison_table",
  "function": "analyze_data",
  "density": "overcrowded",
  "nDataPoints": 18,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de517-44b3-71b5-8a8d-243b41bb1797/20",
  "deckHref": "/decks/019de517-44b3-71b5-8a8d-243b41bb1797",
  "deckJsonHref": "/decks/019de517-44b3-71b5-8a8d-243b41bb1797.json",
  "deckAnchorHref": "/decks/019de517-44b3-71b5-8a8d-243b41bb1797#slide-20",
  "components": [
    {
      "bbox": {
        "h": 0.04,
        "w": 0.147,
        "x": 0.81,
        "y": 0.033
      },
      "kind": "image",
      "text": "GH Research",
      "attrs": {},
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "69a474a6-9e48-4743-bba0-ee76d9e8a3cb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.015,
        "w": 0.16,
        "x": 0.042,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "2023© GH Research PLC",
      "attrs": {
        "numbered": true
      },
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5b808436-34ae-4e33-b4c9-1079ee940f14",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.015,
        "w": 0.018,
        "x": 0.953,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "20",
      "attrs": {
        "numbered": true
      },
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a46bb8ac-6b29-4c63-9725-273789c66e47",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.42,
        "x": 0.068,
        "y": 0.879
      },
      "kind": "source-note",
      "text": "PE, Peak Experience; MADRS, Montgomery-Åsberg Depression Rating Scale; IDR, Individualized Dosing Regimen",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d36ca600-a416-4a6b-bb5d-d98c30d3d900",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.236,
        "w": 0.867,
        "x": 0.068,
        "y": 0.379
      },
      "kind": "table",
      "text": "MADRS Remission Rate Day 7: 87.5% (7 of 8) in Phase 2 (IDR), 50% (2 of 4) in Phase 1 (Single Dose) 12 mg, 25% (1 of 4) in Phase 1 (Single Dose) 18 mg. Mean MADRS Change Day 7: -24.4 (-76%) in Phase 2 (IDR), -21.0 (-65%) in Phase 1 (Single Dose) 12 mg, -12.5 (-40%) in Phase 1 (Single Dose) 18 mg. Rate of PE: 87.5% (7 of 8) in Phase 2 (IDR), 50% (2 of 4) in Phase 1 (Single Dose) 12 mg, 0% (0 of 4) in Phase 1 (Single Dose) 18 mg. Mean PE Score: 90.4 (at final dose) in Phase 2 (IDR), 58.2 in Phase 1 (Single Dose) 12 mg, 59.1 in Phase 1 (Single Dose) 18 mg.",
      "attrs": {},
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3f4d979a-2d4e-45a5-9415-38612b622131",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.11,
        "w": 0.757,
        "x": 0.068,
        "y": 0.073
      },
      "kind": "title",
      "text": "MADRS and PE – Observed Improved Outcome in Phase 2 (IDR) vs Phase 1 (Single Dose)",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3b44daeb-be10-40a5-ba74-9be67c53a154",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Comparison frame",
      "slug": "comparison-frame",
      "agent": null,
      "layer": "slide",
      "matchId": "7f7f3520-dcbd-450b-98b8-a2933b103d3c",
      "evidence": "table/data: MADRS Remission Rate Day 7: 87.5% (7 of 8) in Phase 2 (IDR), 50% (2 of 4) in Phase 1 (Single Dose) 12 mg, 25% (1 of 4) in Phase 1 (Single Dose) 18 mg",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 30,
      "from": 5,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "e59b812c-5781-40d1-880d-5eb666da502e",
      "evidence": "The document emphasizes the limitations of current treatments and the potential of GH001",
      "position": 0,
      "objective": "Highlight the need for more effective depression treatments",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    },
    {
      "to": 30,
      "from": 3,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "a0a779b4-6b2d-4f03-ae8f-5683cc3e54fa",
      "evidence": "The document presents a clear 'why' for GH001, highlighting its potential to provide ultra-rapid, durable remissions",
      "position": 1,
      "objective": "Explain why GH001 is a necessary solution",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.6,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}